Timothy Campbell
Company: Bristol Myers Squibb
Job title: Founder & VP of Biology
Seminars:
CD19-directed CAR-T Cell Therapy Manufactured Using a Next-Generation Process, for Severe, Refractory Autoimmune Diseases 10:30 am
• Optimized autologous CAR-T construct • Translational data for B-cell depletion and immune reset in autoimmune patientsRead more
day: Day Two Track B, AM